$DXCM
AI 分析生成於 May 11, 2026
AI Score
Hold$DXCM
DexCom Inc.
$DXCMNASDAQHealthcareLarge-Cap
Dexcom develops and markets continuous glucose monitoring systems for diabetes management.
Market Cap
$32.0B
Revenue (TTM)
$3.9B
+12.0%
Net Income (TTM)
$0.5B
+20.0%
EPS (TTM)
$1.25
P/E Ratio
80.0
Dividend Yield
0.0%
52-Week Range
$62-$140
Beta
1.15
Dimension Scores
Fundamental
62Technical
58Sentiment
68Risk / Reward
60Momentum
68Financial Health
Profitability
67moderate
Growth
71moderate
Liquidity
68strong
Solvency
64strong
Efficiency
60moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $DXCM
Free · No credit card required
免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。